NeoGenomics (NEO) reported Tuesday Q4 adjusted earnings of $0.04 per diluted share, up from $0.03 a year earlier.
Analysts polled by FactSet expected $0.03.
Net revenue for the quarter ended Dec. 31 was $172 million, up from $155.6 million a year earlier.
Analysts surveyed by FactSet expected $173.2 million.
For 2025, the company expects adjusted diluted EPS of $0.15 to $0.19. Analysts surveyed by FactSet expect $0.20.
The company expects 2025 consolidated revenue of $735 million to $745 million. Analysts polled by FactSet expect $733.1 million.
Shares were down nearly 8% in premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。